In spite of the noise in global markets, it’s August – does anyone care? Investors celebrated the weaker-than-expected U.S. jobs report on Friday, rounding out a week in which both global stocks and bonds rallied. The U.S. jobs report pushed markets to price a higher probability that the Fed will hold rates steady in September and begin cutting later in the year, so stocks – especially more interest-rate sensitive stocks like small caps (e.g. the Russell 2000 index) – ra

It was a highly volatile week in bond and risk markets, which makes it hard to believe that we ended the week about where we started.

This is the 3rd and final article focused on anti-obesity drugs. It looks at valuations of shares of the two giants in this biz, LLY & NVO.

Eli Lilly (LLY) and Novo Nordisk (NVO) have been large players for decades in the market for diabetes medications and are currently...

This article is being published in instalments, of which this is the first, for context. INTRODUCTION Two macrotrends have been drivers...

Debt ceiling drags on, Nvidia clobbers their earnings, and UK inflation rages. Still, equities power forward led by US tech and Japan.